Authors
Abdul Reiyas
Abstract
For the global marketplace, development and regulatory approval of veterinary medicines by the clinical studies that plays a vital role. From clinical research to clinical practice, transfer the knowledge by generating the data from veterinary clinical trials in human and veterinary settings. When product will do work with efficacy and will do no harm (safety), it means of product achieve the success in obtaining the authorization to market in the target population and under the conditions of future use. For veterinary clinical studies, requirements of regulatory that have been developed over the last few years. From Food and Drug Administration (FDA), take the Good Clinical Practice (GCP) guidance documents that provide principle and procedures for safeguard data reproducibility, integrity, and reliability. Clinical studies use in veterinary medicine that has been increasingly common and progresses with some new challenges. In this paper, discuss the quality control and quality assurance for veterinary clinical studies. Keywords: Veterinary Medicine, Clinical Studies
Introduction
Damage to the economic, environmental and social factors by the diseases of animal and in some other cases, it can also threaten the life of a human. Due to the impacts of global changes, many zoonotic infectious disease display global-scale features and many threats are arising out of the livestock industry. On infectious disease, increasing the cost of developing and maintaining research infrastructure due to the higher sophistication of progression of an upgrade of safety regulations as well as technical research approaches for bio-contained research facilities. Continue running the cost of research on bio-contained facilities that is scarce. For this reasons, in 2011, launched a global strategic alliance for the management of research on the animal’s infectious disease (Ducrot et.al 2016).
Veterinary clinical studies have required the regulations that have been developed over the last few years (McPhee and Reimers 2006). To determine the disease of an animal, using a medical intervention (treatment, device, approach) that are designed by veterinary clinical studies which are safe and effective after applying on the client-owned animals. With spontaneous disease (as opposed to experimentally induced models), performed such studies in veterinary patients but performed occasionally studies in healthy client-owned dogs (such as for disease prevention). To evaluate a novel therapeutic or device by increasing the number of clinical trials for the benefits of animal health in veterinary patients that are prior to initiation of human clinical trials (called as translational and comparative trials). ‘One health’ research field contains the important component that is veterinary clinical trials in which affecting and advancing global health by the complex health interaction of human, environment, and animals (Davies et.al 2017).
References
Davies, R., et al. “Quality Assurance and Best Research Practices for Non-Regulated Veterinary Clinical Studies.” BMC Veterinary Research, vol. 13, no. 1, 2017, doi: 10.1186/s12917-017-1153-x.
Ducrot, Christian, et al. “Scientific Literature on Infectious Diseases Affecting Livestock Animals, Longitudinal Worldwide Bibliometric Analysis.” Veterinary Research, vol. 47, no. 1, 2016, doi: 10.1186/s13567-015-0280-2.
Guideline on Good Pharmacovigilance Practices (GVP). Saudi Food and Drug Authority, www.sfda.gov.sa/en/drug/drug_reg/Regulations/Guideline on Good Pharmacovigilance (GVP).pdf.
Hansen, B. D. “Assessment of Pain in Dogs: Veterinary Clinical Studies.” ILAR Journal, vol. 44, no. 3, Jan. 2003, pp. 197–205., doi:10.1093/ilar.44.3.197.
Kerby, Erin. “Research Data Practices in Veterinary Medicine: A Case Study.” Journal of EScience Librarianship, vol. 4, no. 1, 2015, doi:10.7191/jeslib.2015.1073.
Mattson, Donna, and Lindsey Edwards. “Veterinary Clinical Studies: Managing Expectations.” International Animal Health Journal, vol. 2, no. 1, pp. 42–48.
Mcphee, Iain, and Monte Reimers. “The Role of the Monitor in Veterinary Clinical Studies.” The Quality Assurance Journal, vol. 10, no. 3, 2006, pp. 159–181., doi:10.1002/qaj.376.
Oyama, M.a., et al. “Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges.” Journal of Veterinary Internal Medicine, vol. 31, no. 4, 2017, pp. 970–978., doi:10.1111/jvim.14744.
Page, R., et al. “Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations.” Journal of Veterinary Internal Medicine, vol. 30, no. 2, 2016, pp. 527–535., doi:10.1111/jvim.13916.
Rosenfeld, Andrew J., and Sharon M. Dial. Clinical Pathology for the Veterinary Team. Wiley-Blackwell, 2011.
Stockham, Steven L., and Michael A. Scott. Fundamentals of Veterinary Clinical Pathology. Wiley-Blackwell, 2008.
How to cite this article?
| APA Style | Reiyas, A. (2019). Laboratory Approaches in the Field of Veterinary . Academic Journal of Veterinary Sciences, 1(1), 1-6. |
| Chicago Style | |
| MLA Style | |
| DOI | |
| URL |